Ticagrelor Use in Stroke Patients: Past, Present, and Future
Open Access
- 1 June 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in Vascular Health and Risk Management
- Vol. ume 17, 357-362
- https://doi.org/10.2147/vhrm.s266968
Abstract
Antiplatelet medications are the mainstay for secondary stroke treatment. Aspirin, clopidogrel, and aspirin-dipyridamole are commonly used antiplatelet medications. Other antiplatelet medications such as ticagrelor and prasugrel have been majorly used in cardiovascular or neuro-interventional specialties. Recent studies have paved a way to their use in secondary stroke prevention. In this review, we have briefly discussed the pharmacology of ticagrelor, published literature in cardiology and stroke trials, use of ticagrelor among patients with ischemic strokes, and compared its efficacy, limitations and side-effects with other antiplatelet medications.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES TrialStroke, 2018
- Ticagrelor for stroke prevention in patients with vascular risk factors: A systematic review and meta-analysisJournal of the Neurological Sciences, 2018
- Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseThe New England Journal of Medicine, 2017
- Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial InfarctionJournal of the American College of Cardiology, 2016
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic AttackThe New England Journal of Medicine, 2016
- Economic Analysis of Ticagrelor Therapy From a U.S. PerspectiveJournal of Invasive Cardiology, 2015
- Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and SafetyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonismJournal of Thrombosis and Haemostasis, 2013
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) TrialJournal of the American College of Cardiology, 2011
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2009